Andy Weymann combines MD and MBA training with extensive executive experience including Chief Medical Officer and Global Head of Clinical Strategy roles at companies like Smith & Nephew, now applying that operator background directly to early-stage investing and board work at Verve Ventures. He sits at the intersection of venture, startup board work, and corporate innovation with a track record spanning C-suite roles, non-executive directorships, and venture partnership, allowing him to translate between founders, regulators, clinicians, and strategic acquirers in a way that is distinct from more traditional finance- or consulting-only VC backgrounds.